http://www.vaccineblog.org/wordpress The Latest in Vaccine News Sun, 26 Aug 2007 19:06:35 +0000 http://backend.userland.com/rss092 en Antisoma, a biotechnology company specializing in the development of novel drugs for the treatment of cancer, released a statement that the vaccine ASA404 improves anticancer responses and survival for patients with non-small cell lung cancer.ASA404 is known as a vascular disrupting agent (VDA). ASA404 is different from angiogenenesis inhibitors that ... http://www.vaccineblog.org/wordpress/?p=33 Technorati Profile http://www.vaccineblog.org/wordpress/?p=32 THIS week, the international brain trust behind the search for the elusive HIV/AIDS vaccine is meeting in Seattle, a fitting venue as this city grows more renowned for infectious-disease research. Nearly 1,000 scientists from around the world who gathered for the AIDS Vaccine 2007 Conference have a lot to share, much ... http://www.vaccineblog.org/wordpress/?p=31 The influenza vaccine, which is in its early trial stage, has been boosted by a natural sugar adjuvant. The adjuvant amplifies the immune system's response to the virus to increase the effectiveness of vaccines. Research team leader and director of diabetes and endocrinology Professor Nikolai Petrovsky said the sugar-based adjuvant's effect ... http://www.vaccineblog.org/wordpress/?p=30 I'm back, with a new installment about health and the news. Most everyone now has heard of Gardasil and the controversy it has caused in many states, particularly Texas. Those of you that know my opinions well may remember that I was very skeptical of this vaccine against HPV when ... http://www.vaccineblog.org/wordpress/?p=29 The AIDS Vaccine 2007 Conference, featuring researchers and specialists from more than 48 countries, will be hosted all week at the downtown Sheraton in Seattle. Researchers will be discussing the efforts to find an AIDS vaccine. According to conference organizers, the Seattle was chosen for the meeting because of the ... http://www.vaccineblog.org/wordpress/?p=28 Delivering vaccines without the usage of needles might become common in the future if researchers of Tulane University in New Orleans succeed in their efforts. These scientists plan to use nanotechnology to pass the vaccines through the skin. And they received a grant of $2.3 million from the National Institutes ... http://www.vaccineblog.org/wordpress/?p=27 ImmunoCellular Therapeutics, Ltd. (OTCBB:IMUC) announced today that the first three patients have been enrolled in the recently commenced Phase I clinical trial of its lead brain tumor vaccine product candidate. The ... http://www.vaccineblog.org/wordpress/?p=26 A therapeutic cancer vaccine has shown effectiveness when given alongside chemotherapy to patients with metastatic colorectal cancer in a phase II trial, according to researchers at Oxford BioMedica (UK) Ltd. The study found that six of the 17 metastatic colorectal cancer patients in the study showed tumor shrinkage, classified as ... http://www.vaccineblog.org/wordpress/?p=25 Four institutes that conduct advanced research into vaccines are to collaborate and establish an association of institutes this autumn in an attempt to speed up the development of vaccines in Japan, it has been learned. The new association will aim to accelerate vaccine development by lightening the load on pharmaceutical companies ... http://www.vaccineblog.org/wordpress/?p=24